Institutional Ownership
Briacell Therapeutics Corp
CUSIP 107930117*W EXP 99/99/999BCTXZQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Empery Asset Management, LP | 666.6K | $93.3K |
| 2 | Heights Capital Management, Inc | 540.1K | $75.6K |
| 3 | Sabby Management, LLC | 206.8K | $28.9K |
| 4 | Ubs Group AG | 4.7K | $658 |